Skip to main content
. 2014 Feb 3;9(2):e85909. doi: 10.1371/journal.pone.0085909

Figure 5. NCX expression on cellular membrane during A/R.

Figure 5

(A) Double labeling of cultured human cardiomyocyte progenitor cell(hCPC)-derived cardiomyocytes with NCX (red) and Nuclei (blue). Upper row: untreated control (400X). Middle row: increased NCX expression on cellular membrane and cell swelling after A/R (800X). Lower row: levosimendan administered at re-oxygenation and reduced cellular swelling (800X). (B) Western blot for NCX quantification on cellular membrane. Each point represents mean ± S.D. of three independent trials, *p<0.05 and **p<0.01. A/R: anoxia-reoxygenation; Levo: Levosimendan.